It-Chem아이티켐

It-Chem is loss-making, heavily indebted, and its shares have fallen about 48% over the past year.

It-Chem is a Korean specialty chemical maker supplying active pharmaceutical ingredients, OLED display materials and OPC drum materials. Over the trailing twelve months to H1 2026 it reported revenue of about ₩53.1B, an operating loss of about ₩5.5B and a net loss of about ₩17.7B. The share price closed at ₩21,000 on 2026-10-23, far below its 52-week high of ₩55,200.

What stands out

• Trailing revenue of ₩53.1B came with an operating margin of -10.4% and a net margin of -33.4%, so losses widened below the operating line.
• Liabilities are 206.1% of equity, and borrowings of ₩75.8B compare with cash of ₩11.3B.
• Free cash flow over the trailing period was negative at about -₩43.6B.
• Recent filings include an adverse audit opinion on the half-year review with a capital impairment ratio of 50% or more, and an adjustment to the conversion price of a 1st series bond.
• No news headlines were available in the data, and the price was flat over both 1 and 3 months.

What to watch

• The half-year audit flagged capital impairment and equity concerns; further filings on capital or going-concern status would be important.
• Conversion price adjustments and the company's debt and convertible bond obligations, given the negative free cash flow.
• The data does not include forecasts, analyst ratings or a dividend policy, so the outlook is unclear from the information provided.